1. Home
  2. TYRA vs CCSI Comparison

TYRA vs CCSI Comparison

Compare TYRA & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$22.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$23.79

Market Cap

549.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
CCSI
Founded
2018
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
549.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TYRA
CCSI
Price
$22.54
$23.79
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$31.20
$29.00
AVG Volume (30 Days)
570.8K
177.7K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.22
Revenue
N/A
$349,609,000.00
Revenue This Year
N/A
$1.67
Revenue Next Year
N/A
$0.97
P/E Ratio
N/A
$5.63
Revenue Growth
N/A
N/A
52 Week Low
$6.42
$17.84
52 Week High
$24.05
$32.10

Technical Indicators

Market Signals
Indicator
TYRA
CCSI
Relative Strength Index (RSI) 69.31 53.53
Support Level $21.66 $21.92
Resistance Level $24.05 $23.14
Average True Range (ATR) 1.31 0.77
MACD -0.05 0.40
Stochastic Oscillator 67.04 99.36

Price Performance

Historical Comparison
TYRA
CCSI

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

Share on Social Networks: